SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab Chemo for Primary Advanced/Recurrent Endometrial Cancer & PARPi Maintenance in Patients Receiving Dostarlimab Chemo"
vumedi.com
SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab Chemo for Primary Advanced/Recurrent Endometrial Cancer & PARPi Maintenance in Patients Receiving Dostarlimab
A video from Mansoor Raza Mirza (as part of Insights from 2024 SGO Annual Meeting), posted on Apr 9, 2024.
535 viewsApr 9, 2024
Dostarlimab Uses
11 Unusual Uses for Straws
11 Unusual Uses for Straws
instructables.com
554.4K viewsOct 1, 2020
22 Uses for Dryer Sheets (That Aren’t Laundry)
22 Uses for Dryer Sheets (That Aren’t Laundry)
tasteofhome.com
Apr 14, 2022
A new therapy for the most common uterine cancer
2:01
A new therapy for the most common uterine cancer
YouTubeclip SALUTE
2.5K views1 month ago
Top videos
Dostarlimab in Combination with Carboplatin and Paclitaxel for Treatment of dMMR Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Dostarlimab in Combination with Carboplatin and Paclitaxel for Treatment of dMMR Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
targetedonc.com
Sep 21, 2023
Dostarlimab, recommended in final guidance, is set to benefit around 570 people with certain types of primary advanced or recurrent endometrial cancer. Clinical trials show that adding dostarlimab to standard chemotherapy helps women stay well longer⤵️ https://www.nice.org.uk/guidance/ta1064?utm_medium=organic&utm_source=facebook&utm_campaign=dostarlimab_220525&utm_content=finalvideo | National Institute for Health and Care Excellence
0:44
Dostarlimab, recommended in final guidance, is set to benefit around 570 people with certain types of primary advanced or recurrent endometrial cancer. Clinical trials show that adding dostarlimab to standard chemotherapy helps women stay well longer⤵️ https://www.nice.org.uk/guidance/ta1064?utm_medium=organic&utm_source=facebook&utm_campaign=dostarlimab_220525&utm_content=finalvideo | National Institute for Health and Care Excellence
FacebookNational Institute for Health
148 views11 months ago
FDA Approves Dostarlimab Plus Chemo for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer | OncLive
FDA Approves Dostarlimab Plus Chemo for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer | OncLive
onclive.com
Jul 31, 2023
Dostarlimab Side Effects
Side Effects Of Olive Oil: 14 Unexpected Risks
Side Effects Of Olive Oil: 14 Unexpected Risks
stylecraze.com
Jul 29, 2014
EpiPen side effects: What they are and how to manage them
EpiPen side effects: What they are and how to manage them
HealthlineRenee
Jul 15, 2024
Immunotherapy and its side effects | Cancer Research UK
Immunotherapy and its side effects | Cancer Research UK
cancerresearchuk.org
Apr 21, 2020
Dostarlimab in Combination with Carboplatin and Paclitaxel for Treatment of dMMR Endometrial Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Dostarlimab in Combination with Carboplatin and Paclitaxel for Tre…
Sep 21, 2023
targetedonc.com
Dostarlimab, recommended in final guidance, is set to benefit around 570 people with certain types of primary advanced or recurrent endometrial cancer. Clinical trials show that adding dostarlimab to standard chemotherapy helps women stay well longer⤵️ https://www.nice.org.uk/guidance/ta1064?utm_medium=organic&utm_source=facebook&utm_campaign=dostarlimab_220525&utm_content=finalvideo | National Institute for Health and Care Excellence
0:44
Dostarlimab, recommended in final guidance, is set to benefit around …
148 views11 months ago
FacebookNational Institute for Health and Care Excellence
FDA Approves Dostarlimab Plus Chemo for dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer | OncLive
FDA Approves Dostarlimab Plus Chemo for dMMR/MSI-H Primary A…
Jul 31, 2023
onclive.com
Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advanced/Recurrent Endometrial Cancer | OncLive
Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advan…
Sep 4, 2024
onclive.com
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer | OncLive
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo i…
Mar 26, 2025
onclive.com
Dr Mirza on Dostarlimab Plus Chemotherapy in Endometrial Cancer | OncLive
Dr Mirza on Dostarlimab Plus Chemotherapy in Endometrial Can…
Mar 28, 2023
onclive.com
DOMENICA Trial: Dostarlimab vs. Chemo Alone in 1L MMR-Deficient Advanced Endometrial Cancer
DOMENICA Trial: Dostarlimab vs. Chemo Alone in 1L MMR-Deficien…
145 views10 months ago
vumedi.com
: “Dostarlimab farmaco eccezionale per il carcinoma dell’endometrio”
Oct 5, 2022
Il Sole 24 ORE
1:34
Dr. Kristeleit on QoL With Dostarlimab in dMMR/MSI-H Endo…
1.8K viewsSep 30, 2020
YouTubeOncLive
4:34
FDA Approves Dostarlimab / Jemperli for Endometrial Cancer T…
669 viewsAug 6, 2024
YouTubeOncologyTube
3:35
DOSTARLIMAB AND THE AMAZING IMMUNOTHERAPY RESULTS IN R…
13.3K viewsJun 9, 2022
FacebookWilliams Cancer Institute
1:57
Dostarlimab - Jemperli - All You Need to Know in 2 Minutes.
2.5K viewsJul 12, 2024
YouTubePharma Guru
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of L…
9 months ago
onclive.com
2:05
RUBY: assessing secondary endpoints of dostarlimab in endo…
201 views9 months ago
YouTubeVJOncology
ASCO® 2025 Insights: NEO-MEL-T Primary Analysis - Neoadjuvant D…
46 views10 months ago
vumedi.com
2:00
Así funciona Dostarlimab, el fármaco que elimina el cáncer de …
Jun 9, 2022
Antena3.comNeila Gallego
2:06
Phase 3 RUBY Trial: Breakthrough in Endometrial Cancer Treatment …
12 views4 months ago
YouTubeThe Great Connection
1:32
Dr Chase on the FDA Approval of Dostarlimab Plus Chemotherapy i…
1.1K viewsAug 30, 2024
YouTubeOncLive
Jemperli (Dostarlimab Pour Injection) Plus Carboplatine Et Pa…
Nov 16, 2023
zonebourse.com
2:09
Dostarlimab + CP can be a new SOC for patients with primary A/R EC
2.8K viewsJul 3, 2023
YouTubeecancer
0:15
Dostarlimab-Chemotherapy in Advanced Endometrial Cancer
5 months ago
YouTubeJh Li
1:12
Dr Powell on the FDA Approval of Dostarlimab Plus Chemo in Advan…
1.3K viewsSep 5, 2024
YouTubeOncLive
3:29
Time to next treatment by age in the RUBY trial of dostarlimab in endo…
315 views9 months ago
YouTubeVJOncology
Dostarlimab, fármaco experimental que logra remitir el cáncer de colo…
Jun 7, 2022
debate.com.mx
3:31
FDA D.I.S.C.O. Burst Edition: FDA approval of Jemperli (dostarlimab …
572 viewsApr 2, 2024
YouTubeU.S. Food and Drug Administration
12:46
#Dostarlimab | Uses, Dosage, Side Effects and Mechanism | Jemperli
3K viewsSep 8, 2023
YouTubeHe-InFo
7:02
Dostarlimab | immunotherapy: Cure for Cancer? | News Vs Reality | Dr …
11K viewsSep 7, 2022
YouTubeDr Praveen Kammar - GI & Gynaec Cancer Sur…
0:55
The Legacy of Jemperli’s Dostarlimab in Cancer Cure | BLK …
8.2K viewsJun 11, 2022
YouTubeBLK-Max Super Speciality Hospital
4:02
Did we manage to find a cure for cancer? Listen to the cancer speci…
138K viewsJun 8, 2022
FacebookAster Medcity
See more videos
Static thumbnail place holder